Mass Eye and Ear Capital Campaign Concludes with $252 Million Raised to Advance Research and Patient Care

Mass Eye and Ear is proud to announce the successful conclusion of its historic campaign, “Bold Science. Life-Changing Cures.” which raised $252M from philanthropy to advance research to treat and cure diseases of vision, hearing, and the head and neck.
The campaign was led by co-chair Wyc Grousbeck, Boston Celtics CEO and Lead Owner and former Chairman of Mass Eye and Ear.

Read more

Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease

Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma

Read more

Exercise can slow or prevent vision loss, study finds

Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.

Read more

Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease

A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.

Read more